Compare KALV & PNTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KALV | PNTG |
|---|---|---|
| Founded | N/A | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.0B |
| IPO Year | 2014 | 2019 |
| Metric | KALV | PNTG |
|---|---|---|
| Price | $19.95 | $31.66 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 6 |
| Target Price | $32.60 | ★ $36.60 |
| AVG Volume (30 Days) | ★ 1.1M | 233.9K |
| Earning Date | 05-09-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 20.00 |
| EPS | N/A | ★ 0.84 |
| Revenue | $50,000,000.00 | ★ $947,705,000.00 |
| Revenue This Year | $187.19 | $24.72 |
| Revenue Next Year | $54.93 | $7.61 |
| P/E Ratio | ★ N/A | $36.90 |
| Revenue Growth | ★ 495.66 | 36.31 |
| 52 Week Low | $9.83 | $21.74 |
| 52 Week High | $21.31 | $35.25 |
| Indicator | KALV | PNTG |
|---|---|---|
| Relative Strength Index (RSI) | 62.29 | 52.58 |
| Support Level | $14.66 | $28.78 |
| Resistance Level | $21.31 | $31.94 |
| Average True Range (ATR) | 1.35 | 1.08 |
| MACD | 0.14 | -0.00 |
| Stochastic Oscillator | 75.14 | 84.29 |
KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.
Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. It operates in two segments; home health and hospice services and senior living services. The company generates majority of its revenue from home health and hospice services segment, which includes its home health, hospice and home care businesses.